Omega Healthcare Investors stock reports 16.20 percent revenue growth

Published on 09/30/2026 at 22:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Omega Healthcare Investors stock posted Q2 EPS of USD 1.19 versus USD 0.51 consensus in Q2 2026. Fiscal 2026 guidance is USD 3.22-3.26 per share.

OHI, US6821361012, Illustration mit AI erstellt.

Omega Healthcare Investors stock reported Q2 2026 revenue of USD 328.25 million, up 16.20 percent from the prior-year quarter. The healthcare REIT also delivered diluted EPS of USD 1.19 versus USD 0.51 consensus, putting the latest results at the center of the investment case.

Q2 earnings beat expectations

According to MarketBeat on September 15, 2026, Omega's Q2 revenue increased 16.20 percent year over year to USD 328.25 million, while EPS exceeded the USD 0.51 consensus by USD 0.68. The quarter ended June 30, 2026, and the earnings release followed on July 29, 2026.

The comparison needs context. Q2 net income benefited from asset sales, while adjusted funds from operations reached USD 0.83 per share and funds available for distribution reached USD 0.78 per share, according to the company's Q2 earnings call transcript published by Yahoo Finance.

Guidance and dividend shape the outlook

Omega set fiscal 2026 adjusted FFO guidance at USD 3.22-3.26 per share, lifting the midpoint to USD 3.24 from USD 3.22. The company also raised its quarterly dividend to USD 0.68, equivalent to an annualized USD 2.72 per share, according to MarketBeat.

Analyst sentiment remains balanced. The MarketBeat survey cited 15 research firms, with seven Hold ratings, six Buy ratings and two Sell ratings, alongside an average 12-month target of USD 49.50. That mix gives the stock a measurable valuation checkpoint after the earnings beat rather than a one-sided consensus signal.

Next results arrive in November

According to Omega Healthcare Investors, Inc. on September 18, 2026, the company will release Q3 2026 results on November 3, 2026, after market close, followed by a conference call on November 4, 2026, at 10:00 a.m. ET. That date is the next scheduled checkpoint for asset sales, tenant coverage and capital deployment.

Market value and trading range

On September 30, 2026, Omega Healthcare Investors had a market capitalization of USD 13.9 billion on the NYSE. Its 52-week range was USD 39.26-52.39, placing the latest market value within a clearly defined one-year trading band. The company focuses on skilled nursing, assisted living and other long-term healthcare properties leased to operators in the United States and the United Kingdom.